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Strengths and limitations of this study
 ► This is the first study helping fill a knowledge gap 
on what changes to the tobacco cessation treatment 
system in Germany the country’s population would 
agree to.
 ► Data were obtained from a sample which is repre-
sentative of the German population.
 ► The analysis takes into account socio-demographic 
and socio-economic factors as well as smoking sta-
tus of the respondents.
 ► Since the assessed policies are only hypothetical, 
we are unable to say whether public support would 
change in the light of actual implementation.
 ► It would also be important to gain insight into the 
healthcare professionals’ perspective regarding the 
support towards healthcare policies promoting to-
bacco cessation in Germany
AbStrACt
Objective The aim of this study was to assess 
public acceptance of four possible healthcare policies 
supporting tobacco dependence treatment in line with 
the Framework Convention for Tobacco Control, Article 14 
recommendations in Germany.
Design Cross-sectional household survey.
Setting Data were drawn from the German population 
and collected through computer-assisted, face-to-face 
interviews.
Participants Representative random sample of 2087 
people (>14 years) from the German population.
Outcome measures Public acceptance was measured 
regarding (1) treatment cost reimbursement, (2) standard 
training for health professionals on offering cessation 
treatment, and making cessation treatment a standard 
part of care for smokers with (3) physical or (4) mental 
disorders. Association characteristics with smoking status 
and socio-economic status (SES) were assessed.
results Support for all policies was high (50%–68%), 
even among smokers (48%–66%). Ex-smokers and never-
smokers were more likely to support standard training on 
cessation for health professionals than current smokers 
(OR 1.43, 95% CI 1.07 to 1.92; OR 1.43; 95% CI 1.14 to 
1.79, respectively). Ex-smokers were also more likely 
than current smokers to support cessation treatment for 
smokers with mental disorders (OR 1.39, 95% CI 1.11 
to 1.73). Men were less likely than women to support 
cessation treatment for smokers with physical diseases 
(OR 0.74, 95% CI 0.60 to 0.91) and free provision of 
treatment (OR 0.80, 95% CI 0.66 to 0.97). Offering 
cessation treatment to smokers with physical disorders 
was generally more accepted than to those with mental 
health issues.
Conclusions The majority of the German population 
supports healthcare policies to improve the availability 
and affordability of tobacco dependence treatment. Non-
smokers were more supportive than current smokers 
of two of the four policies, but odds of support were 
only about 40% higher. SES characteristics were not 
consistently associated with public acceptance.
trial registration number DRKS00011322.
IntrODuCtIOn
Treating tobacco use is a major public health 
issue: smoking remains a leading cause of 
death, killing approximately 6 million people 
worldwide each year.1 Compared with other 
Western European countries, for example, 
the Netherlands (19%), England (17%) or 
Sweden (7%),2 the prevalence of tobacco 
smoking in Germany remains high (28%).3 
Moreover, smoking is unequally distributed 
across different groups within the popula-
tion, with higher rates of smoking in more 
disadvantaged socio-economic groups3 4 and 
in people with poor mental health.5 Hence, 
interventions to reduce tobacco consumption 
should also aim to decrease tobacco-related 
health inequalities, and smoking cessation 
treatment as part of health services should be 
equally accessible to all social groups.
Article 14 of the WHO Framework Conven-
tion on Tobacco Control (FCTC)1 states that 
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ratifying countries should take effective measures to 
promote cessation of tobacco use and provide adequate 
treatment for tobacco dependence.6 To assist countries 
in fulfilling these obligations, guidelines for the imple-
mentation of Article 14 of the WHO FCTC have been 
developed,6 proposing the following healthcare poli-
cies to reduce national smoking prevalence: integrating 
brief advice to quit smoking into all healthcare systems, 
ensuring that all healthcare workers are trained to 
provide brief smoking cessation support to their smoking 
patients, using existing health infrastructures for access to 
tobacco cessation (including primary care) and making 
evidence-based smoking cessation medication available to 
all smokers wanting to quit, either freel of charge or at 
least at an affordable cost.
Whereas other European countries that ratified the 
FCTC made substantial progress to put these healthcare 
measures into practice, the level of implementation in 
Germany is comparably poor.7 Evidence-based treatments 
are still not, or only partly, reimbursed and stop-smoking 
services rarely exist. According to national clinical 
guidelines, evidence-based cessation methods and brief 
advice to quit tobacco should be routinely offered to 
smoking patients in medical and psychosocial health-
care settings.8 9 However, general practioners (GPs) lack 
training in smoking cessation promotion as training is 
not a standard part of medical education, and to date no 
specific reimbursement is provided to GPs for offering 
brief smoking cessation counselling.10
As a consequence, less than 20% of smokers in Germany 
visiting their GP in the past year report receiving brief 
smoking cessation counselling,11 which contrasts 
with England where half of all smokers report having 
received counselling.12 The majority (>80%) of smokers 
in Germany still try to quit unaided or with the use of 
non-evidence-based treatments,3 and thus limit their 
chances of success.13 Hence, there is an urgent need to 
improve implementation of Article 14 FCTC in German 
healthcare.
Implementation of healthcare policies tackling 
smoking prevalence at population level can only be 
successful if it is broadly accepted by the public and 
used by those affected. However, little is currently 
known about public support for healthcare policies to 
reduce tobacco-related health effects in Germany. The 
few existing studies focus exclusively on public attitudes 
towards tobacco control measures such as increasing 
taxes, improving public education and environmental 
restrictions.14–16
Appropriate data are needed to improve the under-
standing of structural possibilities for the implementa-
tion of policies in German healthcare. Implementation 
usually requires political will, which often relies on under-
standing the level of public support. The German Study 
on Tobacco Use (DEBRA), an ongoing national represen-
tative survey, provides such data.
Objective
The aim of this study was to assess public support for 
possible legislative changes on healthcare policies that, 
according to Article 14 WHO FCTC, should have long 
been implemented in German healthcare.
MethODS
Design, setting and participants
Data on public support for the implementation of potential 
healthcare policies were collected as part of the nationally 
representative DEBRA study (‘DEutsche Befragung zum 
RAuchverhalten’, www. debra- study. info). DEBRA started 
in June 2016 and consists of cross-sectional, computer-as-
sisted household interviews of people aged 14 years and 
older, carried out by a market research institute as part 
of a larger omnibus survey. Over a period of at least 3 
years, a new representative sample of approximately 2000 
respondents of the German population will complete the 
survey every 2 months. Beyond smoking status, smoking 
and quitting behaviour, use of cessation methods and of 
electronic cigarettes, respondents report on socio-demo-
graphic characteristics. Methodological details, including 
details of the sampling approach, as well as the complete 
DEBRA questionnaire have been published in the study 
protocol.17 The study was conducted in accordance with 
the Declaration of Helsinki.
Questions on public support for specific policies were 
asked during wave 2 of the study in August/September 
2016, in a total sample of 2087 respondents. For this wave, 
questions on public acceptance of (a) tobacco control 
strategies and (b) healthcare policy were included. Find-
ings on legislative tobacco control strategies such as a 
total ban of tobacco products or raising the legal age for 
tobacco consumption have been published elsewhere.18 
This article discusses the findings on public attitudes 
towards healthcare policies suggested in Article 14 of the 
WHO FCTC.
Measures
Socio-demographic and smoking characteristics
Socio-demographic data on age, sex, education and net 
household income from all respondents are routinely 
collected in the omnibus survey by the market research 
institute. In the current analysis, the level of education 
of every respondent was categorised from highest to 
lowest as 5=high school equivalent (‘Allgemeine Hoch-
schulreife’), 4=advanced technical college equivalent 
(‘Fachhochschulreife’), 3=secondary school equivalent 
(‘Realschulabschluss’), 2=junior high school equiva-
lent (‘Hauptschulabschluss’) and as 1=no qualification. 
Respondents provided a point estimate of their net 
household income, which was categorised into 6=more 
than 5000€/month, 5=4000 to less than 5000€/month, 
3=2000 to less than 3000€/month, 4=3000 to less than 
4000€/month, 2=1000 to less than 2000€/month and 
1=less than 1000€/month. Respondents were catego-
rised as current tobacco smokers (cigarettes or other 
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combustible tobacco products), as ex-smokers if they had 
stopped during the past year or more than a year ago, or 
as never smokers if they had never smoked for a year or 
longer.
Current smokers of tobacco products were asked 
further details on their smoking behaviour: number of 
cigarettes smoked per day (per week or per month data 
were converted for analyses), about their current moti-
vation to quit smoking using the translated and cultur-
ally adapted German version of the Motivation to Stop 
Smoking Scale,19 and whether or not they made at least 
one quit attempt during the past year.
Measuring public support for healthcare policies
Public support was assessed for four suggestions on 
potential healthcare policies related to tobacco cessa-
tion. These suggestions have been adapted from the 
Smoking Toolkit Study,20 a methodologically comparable 
household survey, allowing comparisons with data from 
England at a later stage.
Participants were asked whether they would (a) 
‘strongly support’, (b) ‘tend to support’, (c) ‘have no 
opinion either way’, (d) ‘tend to oppose’, (e) ‘strongly 
oppose’, or (f) ‘don’t want to answer’ the four statements 
listed below. Answers are classified into ‘agree’ (a and b), 
‘disagree’ (d and e), ‘undecided’ (c) and ‘no answer’ (f), 
and further dichotomised for regression analyses into 
‘agree’ (a and b) and ‘don’t agree’ (c, d and e), with 
those responding ‘f’ excluded.
1. ‘Every smoker who wants should get support that is 
clinically proven to help stop smoking, and costs for 
these treatments (pharmacological or behavioural 
smoking cessation therapy) should be reimbursed’.
2. ‘Making sure that all healthcare professionals direct-
ly involved in the treatment or care of patients are 
trained to advise smokers on how to stop smoking’.
3. ‘Making stop-smoking support a standard part of care 
for smokers with long-term physical health problems 
(such as cardiovascular or respiratory diseases)’.
4. ‘Making stop-smoking support a standard part of care 
for smokers with mental health problems (such as de-
pression or schizophrenia)’.
Statements were asked in a random order to avoid 
primacy and recency effects.21
Data analysis
Descriptive analyses using unweighted data were carried 
out to characterise the total sample, as well as the subsam-
ples, according to the smoking status of respondents. For 
categorical variables, proportions were computed and 
for continuous variables, data were presented in terms of 
means and SD.
To provide prevalence data on public support for 
potential healthcare policies, the sample was weighted to 
be representative of the German population. Details on 
weighting procedures have been published in the study 
protocol.17
Associations between support for suggested healthcare 
policies and sample characteristics were assessed with 
exploratory multivariable logistic regression analyses 
using unweighted data (dichotomous dependent vari-
able ‘agree on a potential healthcare policy’ (agree vs 
disagree)). A second multivariable model was run with 
the subsample of current smokers, assessing associations 
between support for suggested healthcare policies and 
smoking characteristics. Sample characteristics included 
in both models were sex, age, net household income, 
education and smoking status. For the subgroup analysis 
in current smokers, the following smoking characteris-
tics were also included: number of cigarettes smoked per 
day, current motivation to stop smoking18 and attempts 
to quit smoking (any vs none) during the past year. To 
assess whether the subsample of smokers differed from 
the subsample of never-smokers and ex-smokers, we ran 
a third regression model for the latter group separately 
(online supplementary table 1).
Of the total sample, 25 respondents (1.1% of the total 
sample) refused to disclose their smoking status and 
were thus excluded from all analyses. Respondents who 
refused to answer questions on either their educational 
level, their attempts to quit smoking, or on questions 
regarding their support for potential healthcare policies 
were only excluded from the multivariate logistic regres-
sion analyses (statement 1=177 missing (8.6%), statement 
2=187 missing (9.1%), statement 3=179 missing (8.7%) 
and statement 4=245 missing (11.9%)).
reSultS
Sample characteristics
Unweighted baseline characteristics of the analysed 
sample of 2062 respondents with full data on their 
smoking status are presented in table 1. The sample 
had a mean age of 51.8 years (SD=±20 years) and 1070 
(51.9%) respondents were women. In total, 1107 (53.7%, 
95% CI=51%–55%) respondents were never-smokers, 369 
(17.9%, 95% CI=16%–19%) were ex-smokers and 586 
(28.4%, 95% CI=26%–30%; unweighted) were current 
smokers. Table 2 presents data on smoking characteristics 
for this subsample of current smokers.
Public support for healthcare policies
Figure 1 presents rates of support for suggested health-
care policies weighted to be representative for the 
German population. All four policies receive support 
from the majority of the population. Of the total sample, 
52% (95% CI=50%-55%) agreed to providing cessation 
treatment to every smoker for free, 62% (95% CI=60%-
64%) would support standard training on cessation for 
health professionals, 68% (95% CI=66%-70%) would 
support cessation as standard care for patients with 
chronic physical diseases, and half of the sample (50%, 
95%CI=47%–51%) supports cessation for patients with 
mental disorders.
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Table 1 Baseline characteristics of the total sample and by smoking status (unweighted data)*
Total sample
(n=2062; 100%)
Current smoker
(n=586; 28.4%)
Ex-smoker
(n=369; 17.9%)
Never-smoker
(n=1107; 53.7%)
Age, years (mean±SD) 51.8±19.8 47.1±17.2 58.4±17.5 52.1±21.1
Sex
  Female 1070 (51.9%) 271 (46.2%) 143 (38.8%) 656 (59.3%)
  Male 992 (48.1%) 315 (53.8%) 226 (61.2%) 451 (40.7%)
Education†
  High school equiv. 479 (23.2%) 110 (19.2%) 85 (23.2%) 284 (27.4%)
  Adv. tech. college equiv. 133 (6.5%) 28 (4.9%) 30 (8.2%) 75 (7.2%)
  Secondary school equiv. 686 (33.3%) 230 (40.1%) 116 (31.7%) 340 (32.8%)
  Junior high school equiv. 646 (31.3%) 193 (33.6%) 130 (35.5%) 323 (31.1%)
  No qualification 33 (1.6%) 13 (2.3%) 5 (1.4%) 15 (1.4.5%)
Household income
  >€5000/per month 134 (6.5%) 26 (4.4%) 27 (7.3%) 81 (7.3%)
  €4000–5000/per month 128 (6.2%) 31 (5.3%) 24 (6.5%) 73 (6.6%)
  €3000–4000/per month 369 (17.9%) 96 (16.4%) 67 (18.2%) 206 (18.6%)
  €2000–3000/per month 557 (27.0%) 164 (28.0%) 106 (28.7%) 287 (25.9%)
  €1000–2000/per month 638 (30.9%) 173 (29.5%) 117 (31.7%) 348 (31.4%)
  < €1,000/per month 236 (11.4%) 96 (16.4%) 28 (7.6%) 112 (10.1%)
*Baseline characteristics of the sample have also been published elsewhere18 under the Creative Commons Attribution License which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited: CC BY 4.0. Data are presented as 
number (% within row), unless otherwise stated.
†German equivalents to education levels listed in table from highest to lowest: high school equivalent = “Allgemeine Hochschulreife,” 
advanced technical college equivalent = “Fachhochschulreife,” secondary school equivalent = “Realschulabschluss,” junior high school 
equivalent = “Hauptschulabschluss”.
Table 2 Smoking characteristics of current smokers 
(unweighted data)
Current 
smokers 
only
(n=586)
Cigarettes smoked per day (mean+SD) 15.3±9.0
Made at least one quit attempt last year 140 
(23.9%)
Motivation to stop smoking17   
  Don't want to stop smoking 268 
(45.7%)
  Should stop but don't really want to 139 
(23.7%)
  Want to stop but haven't thought about when 52 (8.9%)
  Want to stop but haven’t decided when 51 (8.7%)
  Really want to stop and hope to soon 43 (7.3%)
  Really want to stop and intend to in the next 
3 months
7 (1.2%)
  Really want to stop and intend to in the next 
month
6 (1.0 %)
Data are presented as number (%), unless otherwise stated.
Figure 1 Proportion (with 95% CI) of public support for 
healthcare policies (n=2062 respondents, weighted data).
Among the subsample of current smokers (figure 2), 
the majority also agreed with all four healthcare poli-
cies, with standard cessation provision for patients with 
physical comorbidities, again ranking highest at 66% 
(95% CI=62%-70%). Slightly fewer smokers (54%, 95% 
CI=50%–58%) than in the total sample would support 
standard training for all health professionals.
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Figure 2 Proportion (with 95% CI) of support for healthcare 
policies in the subsample of current smokers (n=586 
respondents, weighted data).
Factors associated with public support
Table 3 presents the results of the multivariable logistic 
regression for the suggested healthcare policies for the 
total unweighted sample and for the subgroup of current 
smokers (for the sake of completeness we ran the regres-
sion model again for the group of never-smokers and 
ex-smokers, please see online supplementary table 1). 
Overall, socio-demographic and smoking characteristics 
are not consistently associated with support for proposed 
healthcare policies, with the exception of sex and smoking 
status.
Men had lower odds of agreeing with (1) free provi-
sion of cessation treatment (OR 0.80, 95% CI 0.66 to 
0.97) than women. Household income showed no signif-
icant associations with support for the policy, while those 
with education levels of junior high school equivalent to 
advanced technical college equivalent had higher odds of 
supporting free provision (OR 1.36, 95% CI 1.03 to 1.79; 
OR 1.34, 95% CI 1.05 to 1.72, OR 1.50, 95% CI 1.00 to 
2.24, respectively).
Standard (2) training of health professionals in cessa-
tion had higher odds of being supported by ex-smokers 
or never-smokers (OR 1.43, 95% CI 1.07 to 1.92 and 
OR 1.43, 95% CI 1.14 to 1.79, respectively) than current 
smokers.
Men were less likely than women to support (3) cessa-
tion as standard care for patients with physical diseases 
(OR 0.74, 95% CI 0.60 to 0.91).
Regarding (4) cessation as standard care for patients 
with mental illness, ex-smokers had significantly higher 
odds than current smokers to agree with this healthcare 
policy (OR 1.39, 95% CI 1.11 to 1.73). Those earning 
less than 1000€/month had higher odds of supporting 
this statement than the highest income group (OR 2.07, 
95% CI 1.29 to 3.31).
Support for policies in the subsample of smokers
When adjusting for socio-demographic characteristics 
(age, sex, education, household income) in the group 
of current smokers (table 3), motivation to quit smoking 
was associated with support for the proposed statement 
that all health professionals should be trained in offering 
cessation support: the higher the motivation to quit, the 
greater the odds that a respondent agreed with the state-
ment (continuous variable, OR 1.20, 95% CI 1.04 to 1.40). 
No further associations between level of support and 
smoking characteristics could be found among current 
smokers.
DISCuSSIOn
Overall, support in Germany is high for four healthcare 
policies that would increase the availability and afford-
ability of tobacco cessation treatment: a majority of the 
adult population supports each of the four policies. 
Smoking status was associated with support for two of the 
four policies, but the odds of agreement were only up to 
40% greater among non-smokers than current smokers. 
These findings are in line with results from 89 surveys on 
smokefree policy in the USA and Canada22; however, a 
study from China found equal support for policies among 
smokers and non-smokers.23 Men were less supportive 
than women, which was also observed in the review from 
the USA and Canada,22 but most socio-economic status 
(SES) characteristics were not consistently associated with 
public acceptance.
Acceptance of standard cessation support for patients 
with chronic physical diseases is higher than of cessa-
tion provision for patients with mental health issues. 
Compared with the highest income group, people in 
the lower income groups expressed higher support for 
standard cessation treatment for the patient group with 
mental health comorbidities. Prevalence of smoking24 25 
and of mental health issues26 is higher in lower SES groups 
in Germany, similar to other European countries,27 which 
could potentially explain these findings. Inequalities also 
persist for seeking treatment for psychiatric disorders in 
Germany.28 Another possible explanation is misconcep-
tion relating to smoking and mental health. A recent 
systematic review found that even among mental health 
professionals, smoking is often perceived as a tool to 
manage stress in patients, and some mental health profes-
sionals believe that quitting smoking may be too much for 
their patients to take on while on treatment.29
A related interesting finding is that the number of 
people not answering whether they support standard 
treatment for patients with mental health comorbidities 
was higher than for other questions. This raises concerns 
about potential stigmatisation of psychiatric illnesses or 
lack of knowledge about mental health in the general 
population in Germany. At the same time, this health-
care policy, in particular, would be of high importance, 
as patients with mental health issues are more susceptible 
to tobacco use5 and could especially profit from standard 
provision of cessation support.30 It could be argued that 
more information about mental health might need to be 
provided to the public. Integrating information on study 
participants' mental health conditions and treatment 
into future or ongoing population surveys could further 
support research on cessation for these groups.
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Table 3 Multivariable associations with support for the proposed healthcare policies in the total sample (n=2062), and in 
current smokers (n=586)
1)Every smoker gets 
cessation treatment 
for free
2)Training all 
healthcare 
professionals to 
advise smokers
3)Cessation support 
as standard care for 
smokers (physical 
diseases)
4)Cessation support 
as standard care 
for smokers (mental 
illness)
Smoking status
  Current smoker (ref.) 1 1 1 1
  Ex-smoker 0.88 (0.67–1.16) 1.43 (1.07–1.92)* 1.37 (1.00–1.88) 1.19 (0.89–1.58)
  Never-smoker 0.88 (0.71–1.09) 1.43 (1.14–1.79)** 1.05 (0.83–1.33) 1.39 (1.11–1.73)**
Age, 10 year units† 1.01 (0.96–1.06) 1.05 (1.00–1.11) 1.06 (1.00–1.13)* 1.05 (1.00–1.11)
Sex
  Female (ref.) 1 1 1 1
  Male 0.80 (0.66–0.97)* 0.83 (0.68–1.01) 0.74 (0.60–0.91)** 0.91 (0.75–1.10)
Education‡
  High school equiv. (ref.) 1 1 1 1
  Adv. tech. college equiv. 1.50 (1.00–2.24)* 1.16 (0.76–1.77) 1.21 (0.77–1.92) 1.41 (0.93–2.13)
  Secondary school equiv. 1.34 (1.05–1.72)* 1.15 (0.88–1.49) 1.02 (0.77–1.34) 1.06 (0.82–1.37)
  Junior high school equiv. 1.36 (1.03–1.79)* 0.99 (0.75–1.32) 0.93 (0.69–1.26) 1.23 (0.93–1.63)
  No qualification 1.07 (0.49–2.34) 1.68 (0.69–4.11) 1.19 (0.49–2.91) 0.86 (0.39–1.91)
Household income
  €>5000/per month (ref.) 1 1 1 1
  €4000–5000/per month 0.99 (0.60–1.64) 0.70 (0.42–1.19) 1.23 (0.69–2.19) 1.32 (0.79–2.21)
  €3000–4000/per month 1.04 (0.69–1.58) 0.88 (0.56–1.36) 1.03 (0.65–1.165) 1.59 (1.04–2.43)*
  €2000–3000/per month 0.92 (0.62–1.38) 0.87 (0.57–1.33) 0.84 (0.54–1.32) 1.39 (0.92–2.10)
  €1000–2000/per month 1.02 (0.68–1.53) 0.91 (0.59–1.40) 1.05 (0.67–1.64) 1.56 (1.03–2.37)*
  < €1,000/per month 1.53 (0.97–2.43) 1.10 (0.67–1.78) 1.22 (0.73–2.04) 2.07 (1.29–3.31)**
Current smokers only (n=586)
  Cigarettes smoked/day, 
number
1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00)
Quit attempt last year (yes/no)
  Yes, attempt to quit (ref.) 1 1 1 1
  No, attempt to quit 0.80 (0.51–1.26) 0.70 (0.44–1.11) 0.91 (0.56–1.48) 0.84 (0.54–1.32)
Motivation to stop smoking 
(MRS)3§
1.00 (0.87–1.14) 1.20 (1.04–1.40)* 1.14 (0.98–1.33) 0.95 (0.83–1.08)
Data are presented as adjusted OR (95% CI around OR). *p<0.05; **p<0.01.
†Continuous variable: age units are based on DEBRA study participation eligibility (14 years and older): 14–23; 24–33; 34–43; 44–53; 54–63; 
64–73; 74–83; 84–93; 94–103.
‡German equivalents to education levels listed in table from highest to lowest: high school equivalent = “Allgemeine Hochschulreife,” 
advanced technical college equivalent = “Fachhochschulreife,” secondary school equivalent = “Realschulabschluss,” junior high school 
equivalent = “Hauptschulabschluss”.
§Continuous variable (MRS: increasing from 1 “don’t want to top” to 7 “really want to stop, intend to in the next month”).
Ref., reference group.
We found sex differences influencing support for two 
statements: support for free cessation treatment among 
current smokers and support for standard treatment for 
patients with physical disorders among the whole sample. 
In each case, men had lower odds of supporting the said 
healthcare policies. Whether disease concepts, including 
concepts of addiction,31 play a role in these differences 
needs to be explored further, ideally using both survey 
data and in-depth qualitative research.
Respondents who indicated a high motivation to quit 
seem to be more supportive of training healthcare profes-
sionals to advise smokers on how to quit tobacco. In 
the light of the fact that the majority of quit attempts in 
Germany occur unaided,3 this result highlights the need 
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for the integration of such training into health profes-
sional education in Germany.
Compared with other European countries, tobacco 
cessation treatment is not well integrated into health-
care in Germany, despite knowledge about the burden 
of the disease caused by tobacco use. The Germany 
SimSmoke study estimated that over 140 000 lives could 
be saved between 2020 and 2040 if cessation treatment 
were provided for free and comprehensively,32 indicating 
a potential for better public health in Germany were such 
policies to be implemented.
This study has some limitations. We were only able 
to pose the healthcare policy support questions in one 
wave of the DEBRA survey due to resource constraints. 
It would be interesting to repeat the assessment in the 
future to gain insights into temporal trends and sensi-
tivity of public acceptance in the light of actual healthcare 
policy changes.
As the proposed healthcare policies would directly 
affect healthcare professionals in their training and 
work, it would be useful to assess not only public 
support, but also healthcare professionals’ support 
towards these measures. However, as DEBRA is a 
nationally representative sample, the findings give good 
insights into the overall population and research with a 
sample of healthcare professionals could complement 
our national study.
The policies assessed here are only hypothetical. We 
are therefore unable to say whether public support would 
change in the light of actual implementation. In addition, 
respondents were not asked about who would pay for free 
cessation treatment. Other studies have found that the 
public is willing to pay for effective tobacco control;33 
however, this willingness to spend has its limits.
Our findings help fill a knowledge gap on what changes 
to the tobacco cessation treatment system in Germany 
the country’s population would agree to. Few studies 
have assessed public support for cessation treatment 
measures instead of tobacco control policies such as 
taxation or smokefree legislation. Information on public 
acceptance of specific tobacco treatment measures is 
even scarcer in Germany than for tobacco control. In 
Germany, DEBRA is one of only a few representative 
surveys targeting smoking and tobacco use behaviour,34 
and is the only one providing both cross-sectional and 
longitudinal data on specific tobacco-related questions 
at 2-month intervals.17
Making cessation treatment a part of standard care 
for patients with physical and mental health disorders is 
a practice that has already been successful elsewhere,35 
and would be in line with the German clinical practice 
guidelines for the treatment of tobacco addiction.8 9 As 
such, these proposed healthcare policies are within the 
realm of the possible. Our findings show that offering 
cessation treatment as standard care in Germany would 
be accepted by the public.
COnCluSIOnS
Public support for integrating tobacco cessation treat-
ment into the health system is high in Germany, in both 
smokers and never-smokers and ex-smokers. Never-
smokers were more supportive than current smokers, but 
it is encouraging that the difference regarding the level 
of support between these two groups is small. Socio-de-
mographic characteristics were not consistently associ-
ated with public acceptance. Offering tobacco cessation 
treatment to patients with physical diseases was gener-
ally more accepted than for patients with mental disor-
ders. Providing cessation treatment offers to all smoking 
patients or, as a bare minimum, to those presenting with 
chronic disorders could be an accepted way forward in 
German tobacco control.
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